Pharmaceuticals Global Industry Almanac 2015-2024

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

– Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

– Any currency conversions used in the production of this report have been calculated at constant 2019 annual average exchange rates.

– Figures presented in this report are calculated applying the "middle path" scenario – this is based on the current situation in countries where the epidemic burst first, like China as a model countries and the announcements made by governments, stating that the abnormal situation may last up to six months.

– The assumption has been made that after this time the economy will gradually go back to the levels recorded before the pandemics by the end of the year. It is also assumed that there is no widespread economic crisis as seen back in 2008 due to announced pay-outs across countries.

– At the moment of preparation of this report in April 2020 the economic implications of the lock downs of many economics are still very difficult to predict as there is no indication how long the pandemics could last, the number of sectors forced to stay closed and the scale of the governmental' aid involved. At the same time the weight of the pandemic seriousness is applied on the individual countries in this report based on death to population ratio recorded in countries.

– Majority of the industries will see the decline in volume of the goods and services offered by companies. Usually the lower demand would cause the decrease the prices level. However, amid many governments’ ordered for many industries to lock down and so the supply chain is distorted that in great pictures mitigate the results of lower demand.

– Applied scenarios differ depending on the individual sector, however generally sectors which involves intensive manual labor and face to face interaction seem to be hit the most by present situation. On the other hand the internet based businesses as well as the producers of the vital, subsisted products and services seems to take advantages of the current events.

– The global pharmaceuticals market had total revenues of $1,057,513.1m in 2019, representing a compound annual growth rate (CAGR) of 3.6% between 2015 and 2019.

– The United States, China, and Japan are some of the largest pharmaceutical markets globally, alongside large European markets such as Germany, France, Spain, and Italy.

– Historically, China is producing some of the strongest growth every year, whilst the European markets have been stifled due to current healthcare spending cultures in the region.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2019?

- What will be the size of the global pharmaceuticals market in 2024?

- What factors are affecting the strength of competition in the global pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the global pharmaceuticals market?

Companies mentioned

A Menarini Industrie Farmaceutiche Riunite Srl

Abdi Ibrahim Ilac Sanayi ve Ticaret AS

Ache Laboratorios Farmaceuticos SA

Adcock Ingram Holdings Ltd

Almirall S.A.

Apotex Pharmachem Inc

Aspen Pharmacare Holdings Ltd

Astellas Pharma Inc.

AstraZeneca AB

Aurobindo Pharma Ltd

Bayer AG

Boehringer Ingelheim GmbH

Chiesi Farmaceutici SpA

Chong Kun Dang Pharmaceutical Corp

Daewoong Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Dr. Reddy's Laboratories Limited

EMS Sigma Pharma

F. Hoffmann-La Roche Ltd

GlaxoSmithKline Plc

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Pharmaceuticals Corp

Hanmi Pharmaceuticals Co Ltd

Johnson & Johnson

Laboratoires Pierre Fabre SA

Les Laboratoires Servier

Lupin Ltd

Merck & Co., Inc.

Mitsubishi Tanabe Pharma Corporation

Novartis AG

Pfizer Inc.

PT Kalbe Farma Tbk

Recordati S.p.A.

Sanofi SA

Shanghai Pharmaceutical Co Ltd

Sun Pharmaceutical Industries Inc

Takeda Pharmaceutical Company Limited

Yangtze River Pharmaceutical Group

Table of Contents

Table of Contents

1 EXECUTIVE SUMMARY

1.1. Market value

1.2. Market value forecast

1.3. Geography segmentation

1.4. Market share

1.5. Competitive Landscape

2 Introduction

2.1. What is this report about?

2.2. Who is the target reader?

2.3. How to use this report

2.4. Definitions

3 Global Pharmaceuticals

3.1. Market Overview

3.2. Market Data

3.3. Market Segmentation

3.4. Market outlook

3.5. Five forces analysis

3.6. Macroeconomic Indicators

4 Pharmaceuticals in Asia-Pacific

4.1. Market Overview

4.2. Market Data

4.3. Market Segmentation

4.4. Market outlook

4.5. Five forces analysis

5 Pharmaceuticals in Europe

5.1. Market Overview

5.2. Market Data

5.3. Market Segmentation

5.4. Market outlook

5.5. Five forces analysis

5.6. Macroeconomic Indicators

6 Pharmaceuticals in France

6.1. Market Overview

6.2. Market Data

6.3. Market Segmentation

6.4. Market outlook

6.5. Five forces analysis

6.6. Macroeconomic Indicators

7 Pharmaceuticals in Germany

7.1. Market Overview

7.2. Market Data

7.3. Market Segmentation

7.4. Market outlook

7.5. Five forces analysis

7.6. Macroeconomic Indicators

8 Pharmaceuticals in Australia

8.1. Market Overview

8.2. Market Data

8.3. Market Segmentation

8.4. Market outlook

8.5. Five forces analysis

8.6. Macroeconomic Indicators

9 Pharmaceuticals in Brazil

9.1. Market Overview

9.2. Market Data

9.3. Market Segmentation

9.4. Market outlook

9.5. Five forces analysis

9.6. Macroeconomic Indicators

10 Pharmaceuticals in Canada

10.1. Market Overview

10.2. Market Data

10.3. Market Segmentation

10.4. Market outlook

10.5. Five forces analysis

10.6. Macroeconomic Indicators

11 Pharmaceuticals in China

11.1. Market Overview

11.2. Market Data

11.3. Market Segmentation

11.4. Market outlook

11.5. Five forces analysis

11.6. Macroeconomic Indicators

12 Pharmaceuticals in India

12.1. Market Overview

12.2. Market Data

12.3. Market Segmentation

12.4. Market outlook

12.5. Five forces analysis

12.6. Macroeconomic Indicators

13 Pharmaceuticals in Indonesia

13.1. Market Overview

13.2. Market Data

13.3. Market Segmentation

13.4. Market outlook

13.5. Five forces analysis

13.6. Macroeconomic Indicators

14 Pharmaceuticals in Italy

14.1. Market Overview

14.2. Market Data

14.3. Market Segmentation

14.4. Market outlook

14.5. Five forces analysis

14.6. Macroeconomic Indicators

15 Pharmaceuticals in Japan

15.1. Market Overview

15.2. Market Data

15.3. Market Segmentation

15.4. Market outlook

15.5. Five forces analysis

15.6. Macroeconomic Indicators

16 Pharmaceuticals in Mexico

16.1. Market Overview

16.2. Market Data

16.3. Market Segmentation

16.4. Market outlook

16.5. Five forces analysis

16.6. Macroeconomic Indicators

17 Pharmaceuticals in The Netherlands

17.1. Market Overview

17.2. Market Data

17.3. Market Segmentation

17.4. Market outlook

17.5. Five forces analysis

17.6. Macroeconomic Indicators

18 Pharmaceuticals in North America

18.1. Market Overview

18.2. Market Data

18.3. Market Segmentation

18.4. Market outlook

18.5. Five forces analysis

19 Pharmaceuticals in Russia

19.1. Market Overview

19.2. Market Data

19.3. Market Segmentation

19.4. Market outlook

19.5. Five forces analysis

19.6. Macroeconomic Indicators

20 Pharmaceuticals in Scandinavia

20.1. Market Overview

20.2. Market Data

20.3. Market Segmentation

20.4. Market outlook

20.5. Five forces analysis

21 Pharmaceuticals in Singapore

21.1. Market Overview

21.2. Market Data

21.3. Market Segmentation

21.4. Market outlook

21.5. Five forces analysis

21.6. Macroeconomic Indicators

22 Pharmaceuticals in South Africa

22.1. Market Overview

22.2. Market Data

22.3. Market Segmentation

22.4. Market outlook

22.5. Five forces analysis

22.6. Macroeconomic Indicators

23 Pharmaceuticals in South Korea

23.1. Market Overview

23.2. Market Data

23.3. Market Segmentation

23.4. Market outlook

23.5. Five forces analysis

23.6. Macroeconomic Indicators

24 Pharmaceuticals in Spain

24.1. Market Overview

24.2. Market Data

24.3. Market Segmentation

24.4. Market outlook

24.5. Five forces analysis

24.6. Macroeconomic Indicators

25 Pharmaceuticals in Turkey

25.1. Market Overview

25.2. Market Data

25.3. Market Segmentation

25.4. Market outlook

25.5. Five forces analysis

25.6. Macroeconomic Indicators

26 Pharmaceuticals in The United Kingdom

26.1. Market Overview

26.2. Market Data

26.3. Market Segmentation

26.4. Market outlook

26.5. Five forces analysis

26.6. Macroeconomic Indicators

27 Pharmaceuticals in The United States

27.1. Market Overview

27.2. Market Data

27.3. Market Segmentation

27.4. Market outlook

27.5. Five forces analysis

27.6. Macroeconomic Indicators

28 Company Profiles

28.1. Johnson & Johnson

28.2. Bayer AG

28.3. Novartis AG

28.4. Pfizer Inc.

28.5. Yangtze River Pharmaceutical Group

28.6. Daiichi Sankyo Co Ltd

28.7. Shanghai Pharmaceutical Co Ltd

28.8. Takeda Pharmaceutical Company Limited

28.9. Chong Kun Dang Pharmaceutical Corp

28.10. F. Hoffmann-La Roche Ltd

28.11. GlaxoSmithKline Plc

28.12. Sanofi SA

28.13. Les Laboratoires Servier

28.14. Laboratoires Pierre Fabre SA

28.15. AstraZeneca AB

28.16. Boehringer Ingelheim GmbH

28.17. EMS Sigma Pharma

28.18. Ache Laboratorios Farmaceuticos SA

28.19. Apotex Pharmachem Inc

28.20. Merck & Co., Inc.

28.21. Guangzhou Pharmaceuticals Corp

28.22. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

28.23. Lupin Ltd

28.24. Sun Pharmaceutical Industries Inc

28.25. Dr. Reddy's Laboratories Limited

28.26. Aurobindo Pharma Ltd

28.27. PT Kalbe Farma Tbk

28.28. A Menarini Industrie Farmaceutiche Riunite Srl

28.29. Recordati S.p.A.

28.30. Chiesi Farmaceutici SpA

28.31. Mitsubishi Tanabe Pharma Corporation

28.32. Astellas Pharma Inc.

28.33. Adcock Ingram Holdings Ltd

28.34. Aspen Pharmacare Holdings Ltd

28.35. Daewoong Pharmaceutical Co Ltd

28.36. Hanmi Pharmaceuticals Co Ltd

28.37. Almirall S.A.

28.38. Abdi Ibrahim Ilac Sanayi ve Ticaret AS

29 Appendix

29.1. Methodology

29.2. About MarketLine

List of Tables

List of Tables

Table 1: Global pharmaceuticals market value: $ billion, 2015-19

Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2019

Table 3: Global pharmaceuticals market share: % share, by value, 2019

Table 4: Global pharmaceuticals market value forecast: $ billion, 2019-24

Table 5: Global size of population (million), 2015-19

Table 6: Global gdp (constant 2005 prices, $ billion), 2015-19

Table 7: Global gdp (current prices, $ billion), 2015-19

Table 8: Global inflation, 2015-19

Table 9: Global consumer price index (absolute), 2015-19

Table 10: Global exchange rate, 2015-19

Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19

Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2019

Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019

Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24

Table 15: Europe pharmaceuticals market value: $ billion, 2015-19

Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2019

Table 17: Europe pharmaceuticals market share: % share, by value, 2019

Table 18: Europe pharmaceuticals market value forecast: $ billion, 2019-24

Table 19: Europe size of population (million), 2015-19

Table 20: Europe gdp (constant 2005 prices, $ billion), 2015-19

Table 21: Europe gdp (current prices, $ billion), 2015-19

Table 22: Europe inflation, 2015-19

Table 23: Europe consumer price index (absolute), 2015-19

Table 24: Europe exchange rate, 2015-19

Table 25: France pharmaceuticals market value: $ billion, 2015-19

Table 26: France pharmaceuticals market geography segmentation: $ billion, 2019

Table 27: France pharmaceuticals market share: % share, by value, 2019

Table 28: France pharmaceuticals market value forecast: $ billion, 2019-24

Table 29: France size of population (million), 2015-19

Table 30: France gdp (constant 2005 prices, $ billion), 2015-19

Table 31: France gdp (current prices, $ billion), 2015-19

Table 32: France inflation, 2015-19

Table 33: France consumer price index (absolute), 2015-19

Table 34: France exchange rate, 2015-19

Table 35: Germany pharmaceuticals market value: $ billion, 2015-19

Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2019

Table 37: Germany pharmaceuticals market share: % share, by value, 2019

Table 38: Germany pharmaceuticals market value forecast: $ billion, 2019-24

Table 39: Germany size of population (million), 2015-19

Table 40: Germany gdp (constant 2005 prices, $ billion), 2015-19

Table 41: Germany gdp (current prices, $ billion), 2015-19

Table 42: Germany inflation, 2015-19

Table 43: Germany consumer price index (absolute), 2015-19

Table 44: Germany exchange rate, 2015-19

Table 45: Australia pharmaceuticals market value: $ billion, 2015-19

Table 46: Australia pharmaceuticals market geography segmentation: $ billion, 2019

Table 47: Australia pharmaceuticals market share: % share, by value, 2019

Table 48: Australia pharmaceuticals market value forecast: $ billion, 2019-24

Table 49: Australia size of population (million), 2015-19

Table 50: Australia gdp (constant 2005 prices, $ billion), 2015-19

Table 51: Australia gdp (current prices, $ billion), 2015-19

Table 52: Australia inflation, 2015-19

Table 53: Australia consumer price index (absolute), 2015-19

Table 54: Australia exchange rate, 2015-19

Table 55: Brazil pharmaceuticals market value: $ billion, 2015-19

Table 56: Brazil pharmaceuticals market geography segmentation: $ billion, 2019

Table 57: Brazil pharmaceuticals market share: % share, by value, 2019

Table 58: Brazil pharmaceuticals market value forecast: $ billion, 2019-24

Table 59: Brazil size of population (million), 2015-19

List of Figures

List of Figures

Figure 1: Global pharmaceuticals market value: $ billion, 2015-19

Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 3: Global pharmaceuticals market share: % share, by value, 2019

Figure 4: Global pharmaceuticals market value forecast: $ billion, 2019-24

Figure 5: Forces driving competition in the global pharmaceuticals market, 2019

Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2019

Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2019

Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2019

Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2019

Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2019

Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2015-19

Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2019

Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2019-24

Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2019

Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2019

Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2019

Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2019

Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2019

Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2019

Figure 21: Europe pharmaceuticals market value: $ billion, 2015-19

Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 23: Europe pharmaceuticals market share: % share, by value, 2019

Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2019-24

Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2019

Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2019

Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2019

Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2019

Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2019

Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2019

Figure 31: France pharmaceuticals market value: $ billion, 2015-19

Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 33: France pharmaceuticals market share: % share, by value, 2019

Figure 34: France pharmaceuticals market value forecast: $ billion, 2019-24

Figure 35: Forces driving competition in the pharmaceuticals market in France, 2019

Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2019

Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2019

Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2019

Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2019

Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2019

Figure 41: Germany pharmaceuticals market value: $ billion, 2015-19

Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 43: Germany pharmaceuticals market share: % share, by value, 2019

Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2019-24

Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2019

Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2019

Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2019

Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2019

Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2019

Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2019

Figure 51: Australia pharmaceuticals market value: $ billion, 2015-19

Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2019

Figure 53: Australia pharmaceuticals market share: % share, by value, 2019

Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2019-24

Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2019

Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2019

Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2019

Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2019

Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2019

Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports